Home/Filings/4/0001601830-25-000005
4//SEC Filing

Li Dean Y 4

Accession 0001601830-25-000005

CIK 0001601830other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 6:02 PM ET

Size

6.9 KB

Accession

0001601830-25-000005

Insider Transaction Report

Form 4
Period: 2025-01-02
Li Dean Y
Director
Transactions
  • Award

    Class A Common Stock

    2025-01-02+1,64777,350 total
Holdings
  • Class A Common Stock

    (indirect: By Trust)
    1,422,048
  • Class A Common Stock

    (indirect: By Trust)
    421,000
  • Class A Common Stock

    (indirect: By Dean Y. Li GRAT)
    1,269,796
Footnotes (1)
  • [F1]The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.

Issuer

RECURSION PHARMACEUTICALS, INC.

CIK 0001601830

Entity typeother

Related Parties

1
  • filerCIK 0001837016

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 6:02 PM ET
Size
6.9 KB